By Mary Gabb ([email protected]) The term “adherence” (or sometimes “compliance”) – the extent to which patients take their treatment as prescribed – has been understood to be a nagging clinical…
Details
By Clare Gurton ([email protected]) When the Harvard Business Review published an article on emotional intelligence several years ago, it attracted a higher percentage of readers than any other article published…
Details
By Kevin Frick ([email protected]) As we provide and interpret pharmacoeconomic (PE) evaluation results for decision makers in different settings around the world, we should consider the standards being followed. And…
Details
By David Woods ([email protected]) US News and World Report calls him a patient safety guru; Modern Healthcare has repeatedly named him among the top 100 most powerful people in American…
Details
By David Woods ([email protected]) Weblogs, or Blogs, have been around for about a decade. Generally viewed as quirky or even anarchic, they may now be gaining a new respectability and…
Details
By Clare Gurton ([email protected]) During a coffee-break at a recent medical conference, I went outside and almost immediately became aware of the familiar sounds of swifts high above. As I…
Details
By David Woods ([email protected]) Newly-installed ISPOR president Diana Brixner, RPh, PhD, has put together a challenging agenda for the society during her term of office. The central point of that…
Details
By David Woods ([email protected]) The Institute of Medicine, which made headlines some years ago when it estimated that medical mistakes kill as many as 98,000 patients a year, followed up…
Details
By Ruth Whittington ([email protected]) Part 4 – Interpreting the results of observational studies In the last of our series on observational studies, this article addresses some of the issues involved…
Details
By Mary Gabb ([email protected]) Billions of emails are sent each day round the world. What most people don’t realise, however, is that email is like a postcard; it can be…
Details
